Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China · Delayed Price · Currency is CNY 20.28
-0.67 (-3.20%)
Sep 29, 2025, 2:46 PM CST
SHE:002755 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,815 | 1,741 | 1,430 | 1,859 | 3,041 | 3,719 | Upgrade |
Other Revenue | 47.67 | 37.05 | 13.77 | 13.61 | 65.22 | 63.37 | Upgrade |
| 1,862 | 1,778 | 1,443 | 1,873 | 3,107 | 3,783 | Upgrade | |
Revenue Growth (YoY) | 12.59% | 23.15% | -22.92% | -39.72% | -17.87% | -16.29% | Upgrade |
Cost of Revenue | 350.32 | 333.53 | 277.51 | 245.7 | 277.05 | 311.44 | Upgrade |
Gross Profit | 1,512 | 1,444 | 1,166 | 1,627 | 2,830 | 3,471 | Upgrade |
Selling, General & Admin | 1,161 | 1,151 | 973.24 | 1,333 | 2,159 | 2,439 | Upgrade |
Research & Development | 143.81 | 177.32 | 472.01 | 588.84 | 324.45 | 255.89 | Upgrade |
Other Operating Expenses | 36.31 | 21.83 | 15.67 | 24.89 | 41.19 | 51.99 | Upgrade |
Operating Expenses | 1,343 | 1,350 | 1,456 | 1,940 | 2,520 | 2,739 | Upgrade |
Operating Income | 169.53 | 94.55 | -290.49 | -313.2 | 309.73 | 732.55 | Upgrade |
Interest Expense | -1.66 | -2.64 | -2.81 | -2.76 | -3.99 | -2.96 | Upgrade |
Interest & Investment Income | 27.28 | 30.99 | 26.78 | 39.89 | 43.72 | 36.58 | Upgrade |
Currency Exchange Gain (Loss) | 0.63 | 1.37 | 0.96 | 0.07 | -0.02 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | -5.31 | -1.8 | -3.19 | -1.89 | -0.08 | -1.77 | Upgrade |
EBT Excluding Unusual Items | 190.48 | 122.46 | -268.75 | -277.89 | 349.36 | 764.35 | Upgrade |
Gain (Loss) on Sale of Investments | 15.46 | 12.73 | 12.5 | 1.68 | 2.39 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.44 | -0.03 | 0.03 | 0.21 | 0.3 | -0.02 | Upgrade |
Asset Writedown | -2.92 | -3.06 | -5.7 | -20.79 | -0.86 | -0.26 | Upgrade |
Other Unusual Items | 27.84 | 19.35 | 60.99 | 34.29 | 54.87 | 57.14 | Upgrade |
Pretax Income | 230.42 | 151.45 | -200.93 | -262.5 | 406.07 | 821.2 | Upgrade |
Income Tax Expense | 19.08 | 22.98 | 6.55 | 3.7 | 25.51 | 95.83 | Upgrade |
Earnings From Continuing Operations | 211.35 | 128.47 | -207.48 | -266.21 | 380.56 | 725.37 | Upgrade |
Minority Interest in Earnings | 33.34 | 31.82 | 58.95 | 40.38 | -0.66 | -3.74 | Upgrade |
Net Income | 244.69 | 160.29 | -148.53 | -225.83 | 379.91 | 721.63 | Upgrade |
Net Income to Common | 244.69 | 160.29 | -148.53 | -225.83 | 379.91 | 721.63 | Upgrade |
Net Income Growth | 186.13% | - | - | - | -47.35% | -7.60% | Upgrade |
Shares Outstanding (Basic) | 941 | 943 | 928 | 941 | 927 | 925 | Upgrade |
Shares Outstanding (Diluted) | 941 | 943 | 928 | 941 | 927 | 925 | Upgrade |
Shares Change (YoY) | 0.67% | 1.57% | -1.34% | 1.55% | 0.16% | -0.49% | Upgrade |
EPS (Basic) | 0.26 | 0.17 | -0.16 | -0.24 | 0.41 | 0.78 | Upgrade |
EPS (Diluted) | 0.26 | 0.17 | -0.16 | -0.24 | 0.41 | 0.78 | Upgrade |
EPS Growth | 184.23% | - | - | - | -47.44% | -7.14% | Upgrade |
Free Cash Flow | 323.69 | 180.94 | -155.89 | -203.27 | 433.95 | 380.7 | Upgrade |
Free Cash Flow Per Share | 0.34 | 0.19 | -0.17 | -0.22 | 0.47 | 0.41 | Upgrade |
Dividend Per Share | 0.120 | 0.120 | - | - | 0.100 | 0.200 | Upgrade |
Dividend Growth | - | - | - | - | -50.00% | -9.09% | Upgrade |
Gross Margin | 81.19% | 81.24% | 80.77% | 86.88% | 91.08% | 91.77% | Upgrade |
Operating Margin | 9.10% | 5.32% | -20.13% | -16.73% | 9.97% | 19.37% | Upgrade |
Profit Margin | 13.14% | 9.02% | -10.29% | -12.06% | 12.23% | 19.08% | Upgrade |
Free Cash Flow Margin | 17.38% | 10.18% | -10.80% | -10.85% | 13.97% | 10.06% | Upgrade |
EBITDA | 264.58 | 169.84 | -208.79 | -224.03 | 401.33 | 825.17 | Upgrade |
EBITDA Margin | 14.21% | 9.55% | -14.46% | -11.96% | 12.92% | 21.81% | Upgrade |
D&A For EBITDA | 95.04 | 75.3 | 81.7 | 89.17 | 91.6 | 92.62 | Upgrade |
EBIT | 169.53 | 94.55 | -290.49 | -313.2 | 309.73 | 732.55 | Upgrade |
EBIT Margin | 9.10% | 5.32% | -20.12% | -16.73% | 9.97% | 19.37% | Upgrade |
Effective Tax Rate | 8.28% | 15.17% | - | - | 6.28% | 11.67% | Upgrade |
Revenue as Reported | 1,862 | 1,778 | 1,443 | 1,873 | 3,107 | 3,783 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.